FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace
Speakers urged clear safety, screening and reimbursement standards as the agency weighs flexible trial designs for treatments that could take years to reach patients.
9 Articles
9 Articles
Experts urge FDA to set clear safety and access standards for psychedelic drugs - Regional Media News
By Puyaan Singh and Kamal Choudhury Sept 14 (Reuters) - Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administration to establish clear safety and access standards for psychedelic therapies during a four-hour public meeting convened by the agency amid efforts [...]
Psychedelic treatments move closer to mainstream at FDA
Psychedelic drug treatments are gaining momentum at the federal level, prompting the Food and Drug Administration to solicit public input on the potential supervised therapeutic use of psychedelic drugs.
FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
By Puyaan Singh and Kamal Choudhury Sept 14 (Reuters) - The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the potential therapeutic use of psychedelic drugs, the latest step in a months-long push by Presid...
FDA should require credentials for psychedelic providers, experts say
As the FDA ramps up its effort to accelerate the development of psychedelic therapies, mental health experts on Monday urged the agency to consider certain safety precautions. The comments came during a four-hour public hearing ...
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium








